Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Injuries & TEE-guided structural heart interventions | USPSTF on hypertension | Telemedicine for stroke survivors
Friday, June 26, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

Injuries common during TEE-guided structural heart interventions—providers urged to weigh options

Overall, 86% of patients included in the study had a new injury once the intervention was complete.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Injuries common during TEE-guided structural heart interventions—providers urged to weigh options

Share on Twitter Share on Facebook Share on Linkedin
Overall, 86% of patients included in the study had a new injury once the intervention was complete.
READ MORE >

USPSTF reaffirms recommendation for hypertension screening among adults

The U.S. Preventive Services Task Force has reaffirmed its recommendation that all adults undergo hypertension screening, calling it “a major contributing risk factor to heart failure, heart attack, stroke and chronic kidney disease.”

READ MORE >
Blood Pressure
Share on Twitter Share on Facebook Share on Linkedin

USPSTF reaffirms recommendation for hypertension screening among adults

Share on Twitter Share on Facebook Share on Linkedin
Blood Pressure
The U.S. Preventive Services Task Force has reaffirmed its recommendation that all adults undergo hypertension screening, calling it “a major contributing risk factor to heart failure, heart attack, stroke and chronic kidney disease.”
READ MORE >

How telemedicine could change the lives of stroke survivors

Approximately one in four stroke survivors are affected by disabling anxiety, but there are currently no specific guidelines in place to help these individuals. Could telemedicine be the answer? 

READ MORE >
Depressed
Share on Twitter Share on Facebook Share on Linkedin

How telemedicine could change the lives of stroke survivors

Share on Twitter Share on Facebook Share on Linkedin
Depressed
Approximately one in four stroke survivors are affected by disabling anxiety, but there are currently no specific guidelines in place to help these individuals. Could telemedicine be the answer? 
READ MORE >

Imaging provider gains FDA clearance, CE mark approval for AI-powered right ventricle assessments

DiA Imaging Analysis has gained FDA clearance and CE mark approval for its AI-powered solution designed to automatically assess right ventricle dysfunction.

READ MORE >
""
Share on Twitter Share on Facebook Share on Linkedin

Imaging provider gains FDA clearance, CE mark approval for AI-powered right ventricle assessments

Share on Twitter Share on Facebook Share on Linkedin
""
DiA Imaging Analysis has gained FDA clearance and CE mark approval for its AI-powered solution designed to automatically assess right ventricle dysfunction.
READ MORE >

Featured Articles

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).
READ MORE >

A fresh look at what does (age, diabetes) and does not (hypertension) predict death from COVID-19

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 

READ MORE >
Covid Hospital
Share on Twitter Share on Facebook Share on Linkedin

A fresh look at what does (age, diabetes) and does not (hypertension) predict death from COVID-19

Share on Twitter Share on Facebook Share on Linkedin
Covid Hospital
A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 
READ MORE >

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Share on Twitter Share on Facebook Share on Linkedin
Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.
READ MORE >

In Other News

Trump administration to end funding for COVID-19 testing sites

The Trump administration is planning to cut funding for 13 drive-thru COVID-19 testing sites at a time when cases and deaths in the U.S. continue to skyrocket, Politico reported.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Trump administration to end funding for COVID-19 testing sites

Share on Twitter Share on Facebook Share on Linkedin
The Trump administration is planning to cut funding for 13 drive-thru COVID-19 testing sites at a time when cases and deaths in the U.S. continue to skyrocket, Politico reported.
READ MORE >

New $40.5M research center dedicated to mapping Alzheimer’s disease

Investigators at the Seattle-based Allen Institute hope to determine how and where the disorder begins and identify new brain cells that are most vulnerable at the onset of the disease.

READ MORE >
Alzheimer's
Share on Twitter Share on Facebook Share on Linkedin

New $40.5M research center dedicated to mapping Alzheimer’s disease

Share on Twitter Share on Facebook Share on Linkedin
Alzheimer's
Investigators at the Seattle-based Allen Institute hope to determine how and where the disorder begins and identify new brain cells that are most vulnerable at the onset of the disease.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme